[go: up one dir, main page]

SI2780003T1 - Treatment of adrenal insufficiency - Google Patents

Treatment of adrenal insufficiency

Info

Publication number
SI2780003T1
SI2780003T1 SI201231759T SI201231759T SI2780003T1 SI 2780003 T1 SI2780003 T1 SI 2780003T1 SI 201231759 T SI201231759 T SI 201231759T SI 201231759 T SI201231759 T SI 201231759T SI 2780003 T1 SI2780003 T1 SI 2780003T1
Authority
SI
Slovenia
Prior art keywords
treatment
adrenal insufficiency
adrenal
insufficiency
Prior art date
Application number
SI201231759T
Other languages
Slovenian (sl)
Inventor
Hiep Huatan
Richard Ross
Martin Whitaker
Original Assignee
Diurnal Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diurnal Limited filed Critical Diurnal Limited
Publication of SI2780003T1 publication Critical patent/SI2780003T1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
SI201231759T 2011-11-19 2012-11-19 Treatment of adrenal insufficiency SI2780003T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1119985.8A GB201119985D0 (en) 2011-11-19 2011-11-19 Treatment of adrenal insufficiency
EP12806617.2A EP2780003B1 (en) 2011-11-19 2012-11-19 Treatment of adrenal insufficiency
PCT/GB2012/052864 WO2013072707A1 (en) 2011-11-19 2012-11-19 Treatment of adrenal insufficiency

Publications (1)

Publication Number Publication Date
SI2780003T1 true SI2780003T1 (en) 2020-07-31

Family

ID=45475414

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201231759T SI2780003T1 (en) 2011-11-19 2012-11-19 Treatment of adrenal insufficiency

Country Status (22)

Country Link
US (2) US9675559B2 (en)
EP (1) EP2780003B1 (en)
JP (2) JP6228125B2 (en)
KR (1) KR101995999B1 (en)
AU (1) AU2012338583B2 (en)
BR (1) BR112014011745B1 (en)
CA (1) CA2854717C (en)
CY (1) CY1123130T1 (en)
DK (1) DK2780003T3 (en)
ES (1) ES2782503T3 (en)
GB (2) GB201119985D0 (en)
HR (1) HRP20200452T1 (en)
HU (1) HUE048445T2 (en)
IL (1) IL232065A (en)
LT (1) LT2780003T (en)
PL (1) PL2780003T3 (en)
PT (1) PT2780003T (en)
RS (1) RS60132B1 (en)
SI (1) SI2780003T1 (en)
SM (1) SMT202000230T1 (en)
WO (1) WO2013072707A1 (en)
ZA (1) ZA201403462B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201119985D0 (en) 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) * 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition
KR102186095B1 (en) 2018-05-14 2020-12-03 주식회사 엘지화학 Compound and organic light emitting device comprising the same
US11904046B1 (en) 2022-11-14 2024-02-20 Eton Pharmaceuticals, Inc. Hydrocortisone oral liquid formulations
WO2025240605A1 (en) 2024-05-15 2025-11-20 Neurocrine Biosciences, Inc. Combination treatment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69101291T2 (en) * 1990-08-30 1994-07-07 Senju Pharma Co Composition for the controlled delivery of medicines.
DK0876142T3 (en) * 1996-01-16 2001-11-19 Advanced Polymer Systems Inc Topical administration of drugs to the lower gastrointestinal tract
CN1244119A (en) * 1997-01-06 2000-02-09 辉瑞大药厂 Rapidly releasing and taste-masking pharmaceutical dosage form
SE0401031D0 (en) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
PL1744760T3 (en) 2004-04-22 2015-04-30 Acucort Ab Pharmaceutical compositions for acute glucocorticoid therapy
US9050249B2 (en) 2004-04-30 2015-06-09 Astellas Pharma Inc. Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition
WO2006026504A2 (en) 2004-08-27 2006-03-09 Spherics, Inc. Mucoadhesive oral formulations of high permeability, high solubility drugs
EP2120868A4 (en) 2007-04-11 2010-08-25 Perrigo Israel Phamaceuticals Low-dose mometasone formulations
JP5461179B2 (en) * 2007-06-06 2014-04-02 旭化成ケミカルズ株式会社 Cellulosic micronucleus particles and method for producing the same
GB0817120D0 (en) 2008-09-19 2008-10-29 Diurnal Ltd Treatment of adrenal insufficiency
US20120183610A1 (en) 2009-04-07 2012-07-19 Lennernaes Hans glucocorticoid therapy
CN102549029B (en) * 2009-09-17 2015-03-04 巴斯夫欧洲公司 Pellets coated with coatings containing active substances
MX337429B (en) 2010-05-20 2016-03-04 Duocort Pharma Ab Posology and administration of glucocorticoid based compositions.
GB201119985D0 (en) 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
GB201308933D0 (en) 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition

Also Published As

Publication number Publication date
IL232065A (en) 2016-04-21
GB201407380D0 (en) 2014-06-11
GB201119985D0 (en) 2012-01-04
ES2782503T3 (en) 2020-09-15
JP2014533679A (en) 2014-12-15
AU2012338583B2 (en) 2017-01-19
HK1194005A1 (en) 2014-10-10
SMT202000230T1 (en) 2020-07-08
GB2509663B (en) 2015-01-07
LT2780003T (en) 2020-04-27
JP6228125B2 (en) 2017-11-08
EP2780003A1 (en) 2014-09-24
ZA201403462B (en) 2016-05-25
US20140287052A1 (en) 2014-09-25
KR101995999B1 (en) 2019-07-03
KR20140108638A (en) 2014-09-12
HUE048445T2 (en) 2020-08-28
PT2780003T (en) 2020-04-08
AU2012338583A1 (en) 2014-05-01
HRP20200452T1 (en) 2020-10-16
BR112014011745A2 (en) 2017-05-30
GB2509663A (en) 2014-07-09
US9717740B1 (en) 2017-08-01
RS60132B1 (en) 2020-05-29
US20170202856A1 (en) 2017-07-20
CY1123130T1 (en) 2021-10-29
EP2780003B1 (en) 2020-02-19
CA2854717A1 (en) 2013-05-23
CA2854717C (en) 2020-12-08
JP2017200942A (en) 2017-11-09
PL2780003T3 (en) 2020-06-29
US9675559B2 (en) 2017-06-13
WO2013072707A1 (en) 2013-05-23
IL232065A0 (en) 2014-05-28
BR112014011745B1 (en) 2022-04-05
DK2780003T3 (en) 2020-03-30

Similar Documents

Publication Publication Date Title
EP2717855A4 (en) Methods of treatment
GB201110095D0 (en) Method of treatment
EP2773754A4 (en) Method of treatment
IL233111A0 (en) Treatment of inflammation
GB201106960D0 (en) Treatment of waste
SG11201400283RA (en) Treatment of rhinitis
EP2685823A4 (en) Treatment of cancer
GB201119774D0 (en) IBS treatment
EP2709665A4 (en) Treatment of psoriasis
ZA201403462B (en) Treatment of adrenal insufficiency
ZA201402154B (en) Treatment of coal
SG2014013585A (en) Method for bonding of substrates
IL231143A0 (en) Treatment of rhinitis
GB201121950D0 (en) Treatment process
EP2791324A4 (en) Method of treatment
GB201100650D0 (en) Treatment of adrenal insufficiency
GB201102798D0 (en) Treatment of adrenal insufficiency
GB201110602D0 (en) Methods of treatment
GB201109737D0 (en) Methods of treatment
GB201121044D0 (en) Treatment of solutions
GB201109266D0 (en) Method of treatment
GB201109509D0 (en) Method of treatment
GB201111530D0 (en) Method of treatment
GB201103044D0 (en) Method of treatment
GB201100651D0 (en) Treatment of inflammation